Latest filing published 22 May 2026 for ALNYLAM PHARMACEUTICALS, INC.. Read the official filing
This profile gathers the share dealings of Dennis A. Ausiello in Alnylam Pharmaceuticals, Inc. Over a trading history stretching from 21 November 2022 to 20 May 2026, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 22 May 2026, the filings show a share grant in Alnylam Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations